|
Apr 23, 2024
|
|
|
|
USC Catalogue 2019-2020 [ARCHIVED CATALOGUE]
Courses of Instruction
|
|
The terms indicated are expected but are not guaranteed. For the courses offered during any given term, consult the Schedule of Classes.
|
|
Removable Prosthodontics |
|
• RPRO 532 Preclinical Removable Partial Prosthodontics Laboratory II
|
|
• RPRO 550 Removable Complete Prosthodontics Clinic I
|
|
• RPRO 561a Clinic: Removable Complete Prosthodontics I
|
|
• RPRO 561b Clinic: Removable Complete Prosthodontics I
|
|
• RPRO 561c Clinic: Removable Complete Prosthodontics I
|
|
• RPRO 561d Clinic: Removable Complete Prosthodontics I
|
|
• RPRO 562a Clinic: Removable Complete Prosthodontics II
|
|
• RPRO 562b Clinic: Removable Complete Prosthodontics II
|
|
• RPRO 571a Clinic: Removable Partial Prosthodontics
|
|
• RPRO 571b Clinic: Removable Partial Prosthodontics
|
|
• RPRO 571c Clinic: Removable Partial Prosthodontics
|
|
• RPRO 571d Clinic: Removable Partial Prosthodontics
|
|
• RPRO 571e Clinic: Removable Partial Prosthodontics
|
|
• RPRO 571f Clinic: Removable Partial Prosthodontics
|
|
• RPRO 602 Advanced Removable Prosthodontics
|
|
• RPRO 603 The Edentulous Patient — Conventional or Implant Prosthesis
|
|
• RPRO 604a Advanced Removable Prosthodontics
|
|
• RPRO 604b Advanced Removable Prosthodontics
|
|
• RPRO 604c Advanced Removable Prosthodontics
|
|
• RPRO 605 Prosthodontic Seminar: Removable Partial Prosthodontics
|
Regulatory Science |
|
• RSCI 504 Good Laboratory Practices (GLP)
|
|
• RSCI 506 Auditing Principles
|
|
• RSCI 507 Quality Systems and Statistical Process Control
|
|
• RSCI 508 Quality Assurance for Drugs and Biologics
|
|
• RSCI 509 Quality Assurance, Medical Devices and Combination Products
|
|
• RSCI 520 Introduction to Risk Management for Health Care Products
|
|
• RSCI 521 Seminars in Regulatory Science
|
|
• RSCI 523 Advanced Concepts in Risk Management for Medical Products
|
|
• RSCI 525 Introduction to Drug and Food Toxicology
|
|
• RSCI 527 Medical Product Safety
|
|
• RSCI 529 Application of Risk Management Tools and Techniques
|
|
• RSCI 531 Industrial Approaches to Drug Discovery
|
|
• RSCI 532 Early Stage Drug Development
|
|
• RSCI 533 Safety Evaluation during Drug Development
|
|
• RSCI 534 Drug Development in CNS Disorders
|
|
• RSCI 535 Methods Development and Validation
|
|
• RSCI 540 Analysis of Food and Dietary Supplement Regulations
|
|
• RSCI 541 Drug Development, Reimbursement, and Marketing
|
|
• RSCI 590 Directed Research
|
|
• RSCI 596 Internship for Curricular Practical Training in Regulatory Science
|
|
• RSCI 601 Biomedical Commerce
|
|
• RSCI 603 Managing Complex Projects
|
|
• RSCI 604 Regulatory Strategy in Asia
|
|
• RSCI 605 Managing Organizations and Human Resources
|
|
• RSCI 606 Regulation of Emerging Technologies and Biological Products
|
|
• RSCI 607 Theory, Methods and Practice of Medical Products Research
|
|
• RSCI 608 Regulatory Strategy in Europe and the Americas
|
|
• RSCI 790 Directed Research
|
|
• RSCI 794a Doctoral Dissertation
|
|
• RSCI 794b Doctoral Dissertation
|
|
• RSCI 794c Doctoral Dissertation
|
|
• RSCI 794d Doctoral Dissertation
|
|
• RSCI 794z Doctoral Dissertation
|
|
• RSCI 800 Studies for the Qualifying Exam
|
Russian |
|
• RUSS 120 Beginning Russian I
|
|
• RUSS 150 Beginning Russian II
|
|
• RUSS 220 Intermediate Russian I
|
|
• RUSS 250 Intermediate Russian II
|
|
• RUSS 260x The Trans-Siberian Experience
|
|
• RUSS 310 Advanced Russian in Popular Culture
|
Pharmaceutical and Regulatory Science |
|
• RXRS 201p The History and Geography of Drugs
|
|
• RXRS 302 Pharmacology and Drug Development
|
|
• RXRS 304 Mysterious Deaths: Toxicology, Poisons, Literature, History
|
|
• RXRS 402 Human Pharmacology: Challenge of Therapeutics in Society
|
|
• RXRS 403 Neuropharmacology in Health and Disease
|
|
• RXRS 404 Neuroimmunity in Health and Disease
|
|
• RXRS 405 Pharmacology and Sociology of Drug Abuse
|
|
• RXRS 406 Clinical Pharmacology and Medication Management
|
|
• RXRS 407 The Discovery, Development and Marketing of Medicines
|
|
• RXRS 408 Immunology and Immunotherapeutics
|
|
• RXRS 409 Neuroimmunology: Focus on Disease and Therapy
|
|
• RXRS 410 Cancer Biology and Pharmacotherapy
|
|
• RXRS 411 Innovations in Medical Product Development
|
|
• RXRS 412 Twenty-First Century Medical Issues and the Law
|
|
• RXRS 413w Globalization of the Biomedical Industry
|
|
• RXRS 414 Buzzed: Modern Substances of Abuse and Addiction
|
|
• RXRS 416 Medical Products: From Idea to Market
|
|
• RXRS 417 Food Safety: The Good, The Bad and The Deadly
|
|
• RXRS 418 Plant Medicines in Modern Medicine
|
|
• RXRS 420 Organ Physiology, Drug Delivery, and Drug Action
|
|
• RXRS 490x Directed Research
|
Systems Architecting and Engineering |
|
• SAE 496 Systems Engineering Through Motorsports
|
|
• SAE 499 Special Topics
|
|
• SAE 515 Sustainable Infrastructure Systems
|
|
• SAE 541 Systems Engineering Theory and Practice
|
|
• SAE 542 Advanced Topics in Systems Engineering
|
|
• SAE 543 Case Studies in Systems Engineering and Management
|
|
• SAE 546 Engineered Resilient Systems and System-of-Systems
|
|
• SAE 547 Model-Based Systems Architecting and Engineering
|
|
• SAE 548 Systems/System-of-Systems Integration and Communication
|
|
• SAE 549 Systems Architecting
|
|
• SAE 550 Systems Architecting and the Political Process
|
|
• SAE 551 Lean Operations
|
|
• SAE 560 Economic Considerations for Systems Engineering
|
|
• SAE 574 Net-Centric Systems Architecting and Engineering
|
|
• SAE 590 Directed Research
|
|
• SAE 594a Master’s Thesis
|
|
• SAE 594b Master’s Thesis
|
|
• SAE 594z Master’s Thesis
|
|
• SAE 599 Special Topics
|
|
Page: 1 <- Back 10 … 103
| 104
| 105
| 106
| 107
| 108
| 109
| 110
| 111
| 112
| 113
-> 118 |
|
|
You must be logged in to post a comment.